Combination radioimmunotherapy with local hyperthermia: increased delivery of radioimmunoconjugate by vascular effect and its retention by increased antigen expression in colon cancer xenografts

被引:12
作者
Kinuya, S
Yokoyama, K
Hiramatsu, T
Tega, H
Tanaka, K
Konishi, S
Shuke, N
Aburano, T
Watanabe, N
Takayama, T
Michigishi, T
Tonami, N
机构
[1] Kanazawa Univ, Sch Med, Dept Nucl Med, Kanazawa, Ishikawa 9208640, Japan
[2] Asahikawa Med Coll, Dept Radiol, Asahikawa, Hokkaido 0788510, Japan
[3] Toyama Med & Pharmaceut Univ, Dept Radiol, Toyama 9300194, Japan
[4] Kanazawa Univ, Sch Hlth Sci, Dept Radiol Technol, Kanazawa, Ishikawa 9200942, Japan
关键词
radioimmunotherapy; hyperthermia; antigen expression; tumor blood flow; vascular permeability;
D O I
10.1016/S0304-3835(99)00090-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hyperthermia (HT) may increase tumor targeting of a radiolabeled antibody by its effects on tumor vasculature and antigen expression. Expression of a 45-kDa glycoprotein antigen on LS180 colon cancer cells was 2.7-fold enhanced 2 days after heating at 43 degrees C for 1 h, Preferential tumor accumulation of I-125-A7 recognizing this antigen was doubled and the antitumor effect of I-131-A7 was significantly improved by HT. Hyperthermia also increased tumor uptake of an irrelevant antibody but its radioactivity was rapidly cleared. These results indicate that HT increased the initial delivery of an antibody to a tumor by its vascular effect, and radioactivity was retained in tumors by increased specific binding, resulting in a better radioimmunotherapy outcome. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:209 / 218
页数:10
相关论文
共 40 条
[1]  
Behr TM, 1997, J NUCL MED, V38, P858
[2]  
BREITZ HB, 1992, J NUCL MED, V33, P1099
[3]  
BUCHEGGER F, 1990, J NUCL MED, V31, P1035
[4]  
CAPONE PM, 1984, J NATL CANCER I, V72, P673
[5]  
COPE DA, 1990, CANCER RES, V50, P1803
[6]  
DAVIES CD, 1985, CANCER RES, V45, P4109
[7]  
DAVIES CDL, 1990, INT J HYPERTHER, V6, P1053, DOI 10.3109/02656739009140988
[8]   Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: Efficacy and toxicity in breast cancer xenografts [J].
DeNardo, SJ ;
Kukis, DL ;
Kroger, LA ;
ODonnell, RT ;
Lamborn, KR ;
Miers, LA ;
DeNardo, DG ;
Meares, CF ;
DeNardo, GL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :4000-4004
[9]   ALTERATIONS IN TUMOR MICROVASCULATURE DURING HYPERTHERMIA [J].
EDDY, HA .
RADIOLOGY, 1980, 137 (02) :515-521
[10]  
GRIDLEY DS, 1991, CANCER RES, V51, P1515